Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 24 entries
Sorted by: Best Match Show Resources per page
Surgery effective for advanced form of prostate cancer.

Mayo Clinic health letter (English ed.)

[No authors listed]
PMID: 16229075
Mayo Clin Health Lett. 2005 Aug;23(8):4.

No abstract available.

Cite
Surgery effective for advanced form of prostate cancer. Mayo Clin Health Lett. 2005;23(8):4
(2005). Surgery effective for advanced form of prostate cancer. Mayo Clinic health letter (English ed.), 23(8), 4.
"Surgery effective for advanced form of prostate cancer." Mayo Clinic health letter (English ed.) vol. 23,8 (2005): 4.
Surgery effective for advanced form of prostate cancer. Mayo Clin Health Lett. 2005 Aug;23(8):4. PMID: 16229075.
Copy Download .nbib Format: NLM
Is surgery good for advanced localised prostate cancer? It's time to find out!.

European urology

Lange PH.
PMID: 17070648
Eur Urol. 2007 Apr;51(4):873-5. doi: 10.1016/j.eururo.2006.09.044. Epub 2006 Oct 17.

No abstract available.

Cite
Lange PH. Is surgery good for advanced localised prostate cancer? It's time to find out!. Eur Urol. 2006;51(4):873-5doi: 10.1016/j.eururo.2006.09.044.
Lange, P. H. (2007). Is surgery good for advanced localised prostate cancer? It's time to find out!. European urology, 51(4), 873-5. https://doi.org/10.1016/j.eururo.2006.09.044
Lange, Paul H. "Is surgery good for advanced localised prostate cancer? It's time to find out!." European urology vol. 51,4 (2007): 873-5. doi: https://doi.org/10.1016/j.eururo.2006.09.044
Lange PH. Is surgery good for advanced localised prostate cancer? It's time to find out!. Eur Urol. 2007 Apr;51(4):873-5. doi: 10.1016/j.eururo.2006.09.044. Epub 2006 Oct 17. PMID: 17070648.
Copy Download .nbib Format: NLM
The role of surgery in high-risk localised prostate cancer.

BJU international

Thurairaja R, Koupparis A.
PMID: 22691024
BJU Int. 2012 Jul;110(1):E1-2. doi: 10.1111/j.1464-410X.2012.11303_2.x.

No abstract available.

Cite
Thurairaja R, Koupparis A. The role of surgery in high-risk localised prostate cancer. BJU Int. 2012;110(1):E1-2doi: 10.1111/j.1464-410X.2012.11303_2.x.
Thurairaja, R., & Koupparis, A. (2012). The role of surgery in high-risk localised prostate cancer. BJU international, 110(1), E1-2. https://doi.org/10.1111/j.1464-410X.2012.11303_2.x
Thurairaja, Ramesh, and Koupparis, Anthony. "The role of surgery in high-risk localised prostate cancer." BJU international vol. 110,1 (2012): E1-2. doi: https://doi.org/10.1111/j.1464-410X.2012.11303_2.x
Thurairaja R, Koupparis A. The role of surgery in high-risk localised prostate cancer. BJU Int. 2012 Jul;110(1):E1-2. doi: 10.1111/j.1464-410X.2012.11303_2.x. PMID: 22691024.
Copy Download .nbib Format: NLM
Late urinary symptom flare after prostate stereotactic body radiation therapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Collins SP, Suy S, Chen LN, Collins BT, Lynch J, Dritschilo A.
PMID: 25185102
J Clin Oncol. 2014 Oct 20;32(30):3451-2. doi: 10.1200/JCO.2014.56.6547. Epub 2014 Sep 02.

No abstract available.

Cite
Collins SP, Suy S, Chen LN, et al. Late urinary symptom flare after prostate stereotactic body radiation therapy. J Clin Oncol. 2014;32(30):3451-2doi: 10.1200/JCO.2014.56.6547.
Collins, S. P., Suy, S., Chen, L. N., Collins, B. T., Lynch, J., & Dritschilo, A. (2014). Late urinary symptom flare after prostate stereotactic body radiation therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(30), 3451-2. https://doi.org/10.1200/JCO.2014.56.6547
Collins, Sean P, et al. "Late urinary symptom flare after prostate stereotactic body radiation therapy." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 32,30 (2014): 3451-2. doi: https://doi.org/10.1200/JCO.2014.56.6547
Collins SP, Suy S, Chen LN, Collins BT, Lynch J, Dritschilo A. Late urinary symptom flare after prostate stereotactic body radiation therapy. J Clin Oncol. 2014 Oct 20;32(30):3451-2. doi: 10.1200/JCO.2014.56.6547. Epub 2014 Sep 02. PMID: 25185102.
Copy Download .nbib Format: NLM
Surgery or radiation: is there really a choice for early prostate cancer.

Critical reviews in oncology/hematology

Van Erps P, Van Den Weyngaert D, Denis L.
PMID: 9548015
Crit Rev Oncol Hematol. 1998 Jan;27(1):11-27. doi: 10.1016/s1040-8428(97)10005-1.

One of the most difficult tasks for the practicing urologist is to counsel the patient in a decision for the optimal treatment for his localized prostate cancer. After providing the patient with contemporary and unbiased information and data, it...

Cite
Van Erps P, Van Den Weyngaert D, Denis L. Surgery or radiation: is there really a choice for early prostate cancer. Crit Rev Oncol Hematol. 1998;27(1):11-27doi: 10.1016/s1040-8428(97)10005-1.
Van Erps, P., Van Den Weyngaert, D., & Denis, L. (1998). Surgery or radiation: is there really a choice for early prostate cancer. Critical reviews in oncology/hematology, 27(1), 11-27. https://doi.org/10.1016/s1040-8428(97)10005-1
Van Erps, P, et al. "Surgery or radiation: is there really a choice for early prostate cancer." Critical reviews in oncology/hematology vol. 27,1 (1998): 11-27. doi: https://doi.org/10.1016/s1040-8428(97)10005-1
Van Erps P, Van Den Weyngaert D, Denis L. Surgery or radiation: is there really a choice for early prostate cancer. Crit Rev Oncol Hematol. 1998 Jan;27(1):11-27. doi: 10.1016/s1040-8428(97)10005-1. PMID: 9548015.
Copy Download .nbib Format: NLM
Focal therapy for prostate cancer - index lesion treatment vs. hemiablation. A matter of definition.

International braz j urol : official journal of the Brazilian Society of Urology

Stabile A, Moschini M, Montorsi F, Cathelineau X, Sanchez-Salas R.
PMID: 31626515
Int Braz J Urol. 2019 Sep-Oct;45(5):873-876. doi: 10.1590/S1677-5538.IBJU.2019.05.02.

No abstract available.

Cite
Stabile A, Moschini M, Montorsi F, et al. Focal therapy for prostate cancer - index lesion treatment vs. hemiablation. A matter of definition. Int Braz J Urol. 2019;45(5):873-876doi: 10.1590/S1677-5538.IBJU.2019.05.02.
Stabile, A., Moschini, M., Montorsi, F., Cathelineau, X., & Sanchez-Salas, R. (2019). Focal therapy for prostate cancer - index lesion treatment vs. hemiablation. A matter of definition. International braz j urol : official journal of the Brazilian Society of Urology, 45(5), 873-876. https://doi.org/10.1590/S1677-5538.IBJU.2019.05.02
Stabile, Armando, et al. "Focal therapy for prostate cancer - index lesion treatment vs. hemiablation. A matter of definition." International braz j urol : official journal of the Brazilian Society of Urology vol. 45,5 (2019): 873-876. doi: https://doi.org/10.1590/S1677-5538.IBJU.2019.05.02
Stabile A, Moschini M, Montorsi F, Cathelineau X, Sanchez-Salas R. Focal therapy for prostate cancer - index lesion treatment vs. hemiablation. A matter of definition. Int Braz J Urol. 2019 Sep-Oct;45(5):873-876. doi: 10.1590/S1677-5538.IBJU.2019.05.02. PMID: 31626515; PMCID: PMC6844335.
Copy Download .nbib Format: NLM
Focal bipolar radiofrequency ablation for localized prostate cancer: Safety and feasibility.

International journal of urology : official journal of the Japanese Urological Association

Aydin AM, Gage K, Dhillon J, Cheriyan SK, Poch MA, Manley BJ, Li R, Sexton WJ, Spiess PE, Gilbert SM, Pow-Sang JM.
PMID: 32767444
Int J Urol. 2020 Oct;27(10):882-889. doi: 10.1111/iju.14321. Epub 2020 Aug 06.

OBJECTIVES: To evaluate the safety and feasibility of focal bipolar radiofrequency ablation in men with localized prostate cancer.METHODS: A review of 10 patients treated with a novel bipolar radiofrequency ablation probe integrated in a coil design (Encage; Trod Medical,...

Cite
Aydin AM, Gage K, Dhillon J, et al. Focal bipolar radiofrequency ablation for localized prostate cancer: Safety and feasibility. Int J Urol. 2020;27(10):882-889doi: 10.1111/iju.14321.
Aydin, A. M., Gage, K., Dhillon, J., Cheriyan, S. K., Poch, M. A., Manley, B. J., Li, R., Sexton, W. J., Spiess, P. E., Gilbert, S. M., & Pow-Sang, J. M. (2020). Focal bipolar radiofrequency ablation for localized prostate cancer: Safety and feasibility. International journal of urology : official journal of the Japanese Urological Association, 27(10), 882-889. https://doi.org/10.1111/iju.14321
Aydin, Ahmet Murat, et al. "Focal bipolar radiofrequency ablation for localized prostate cancer: Safety and feasibility." International journal of urology : official journal of the Japanese Urological Association vol. 27,10 (2020): 882-889. doi: https://doi.org/10.1111/iju.14321
Aydin AM, Gage K, Dhillon J, Cheriyan SK, Poch MA, Manley BJ, Li R, Sexton WJ, Spiess PE, Gilbert SM, Pow-Sang JM. Focal bipolar radiofrequency ablation for localized prostate cancer: Safety and feasibility. Int J Urol. 2020 Oct;27(10):882-889. doi: 10.1111/iju.14321. Epub 2020 Aug 06. PMID: 32767444.
Copy Download .nbib Format: NLM
Current conflicts in the management of prostatic cancer.

International journal of radiation oncology, biology, physics

Bagshaw MA.
PMID: 3759523
Int J Radiat Oncol Biol Phys. 1986 Oct;12(10):1721-7. doi: 10.1016/0360-3016(86)90311-1.

In summary, 5-, 10-, and 15-year actuarial survival can be achieved in 81, 60, and 35% of patients with disease limited to the prostate and in 61, 36, and 18% of those with extracapsular extension. In various subgroups of...

Cite
Bagshaw MA. Current conflicts in the management of prostatic cancer. Int J Radiat Oncol Biol Phys. 1986;12(10):1721-7doi: 10.1016/0360-3016(86)90311-1.
Bagshaw, M. A. (1986). Current conflicts in the management of prostatic cancer. International journal of radiation oncology, biology, physics, 12(10), 1721-7. https://doi.org/10.1016/0360-3016(86)90311-1
Bagshaw, M A. "Current conflicts in the management of prostatic cancer." International journal of radiation oncology, biology, physics vol. 12,10 (1986): 1721-7. doi: https://doi.org/10.1016/0360-3016(86)90311-1
Bagshaw MA. Current conflicts in the management of prostatic cancer. Int J Radiat Oncol Biol Phys. 1986 Oct;12(10):1721-7. doi: 10.1016/0360-3016(86)90311-1. PMID: 3759523.
Copy Download .nbib Format: NLM
The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis.

World journal of surgical oncology

Cheng B, Ye S, Bai P.
PMID: 34051809
World J Surg Oncol. 2021 May 29;19(1):160. doi: 10.1186/s12957-021-02265-8.

BACKGROUNDS: At present, the application of tumor reduction surgery in oligometastatic prostate cancer has aroused extensive discussion among urologists, but clinicians have not reached a consensus on this issue. The purpose of this study was to evaluate the effect...

Cite
Cheng B, Ye S, Bai P. The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis. World J Surg Oncol. 2021;19(1):160doi: 10.1186/s12957-021-02265-8.
Cheng, B., Ye, S., & Bai, P. (2021). The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis. World journal of surgical oncology, 19(1), 160. https://doi.org/10.1186/s12957-021-02265-8
Cheng, Bisheng, et al. "The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis." World journal of surgical oncology vol. 19,1 (2021): 160. doi: https://doi.org/10.1186/s12957-021-02265-8
Cheng B, Ye S, Bai P. The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis. World J Surg Oncol. 2021 May 29;19(1):160. doi: 10.1186/s12957-021-02265-8. PMID: 34051809; PMCID: PMC8164769.
Copy Download .nbib Format: NLM
[Prostatic ductal carcinoma].

Archivos espanoles de urologia

Llarena Ibarguren R, Lecumberri Castaños D, Padilla Nieva J, Crespo Atín V, Martín Bazaco J, Azurmendi Sastre V, Eizaguirre Zarza B, Pertusa Peña C.
PMID: 14674295
Arch Esp Urol. 2003 Nov;56(9):1054-8.

OBJECTIVES: We presented one case of prostatic adenocarcinoma of ductal origin, known as endometrial adenocarcinoma before. The first case was published in 1967 by Mellicow. Since then we could only recover 8 cases by spanish authors.METHODS/RESULTS: 61-year-old patient presenting...

Cite
Llarena Ibarguren R, Lecumberri Castaños D, Padilla Nieva J, et al. Carcinoma ductal prostático. [Prostatic ductal carcinoma]. Arch Esp Urol. 2003;56(9):1054-8
Llarena Ibarguren, R., Lecumberri Castaños, D., Padilla Nieva, J., Crespo Atín, V., Martín Bazaco, J., Azurmendi Sastre, V., Eizaguirre Zarza, B., & Pertusa Peña, C. (2003). Carcinoma ductal prostático. [Prostatic ductal carcinoma]. Archivos espanoles de urologia, 56(9), 1054-8.
Llarena Ibarguren, Roberto, et al. "Carcinoma ductal prostático." [Prostatic ductal carcinoma]. Archivos espanoles de urologia vol. 56,9 (2003): 1054-8.
Llarena Ibarguren R, Lecumberri Castaños D, Padilla Nieva J, Crespo Atín V, Martín Bazaco J, Azurmendi Sastre V, Eizaguirre Zarza B, Pertusa Peña C. Carcinoma ductal prostático. [Prostatic ductal carcinoma]. Arch Esp Urol. 2003 Nov;56(9):1054-8. Spanish. PMID: 14674295.
Copy Download .nbib Format: NLM
MR imaging-guided prostate interventional imaging: Ready for a clinical use?.

Diagnostic and interventional imaging

Cornud F, Bomers J, Futterer JJ, Ghai S, Reijnen JS, Tempany C.
PMID: 30190189
Diagn Interv Imaging. 2018 Nov;99(11):743-753. doi: 10.1016/j.diii.2018.08.002. Epub 2018 Sep 03.

Prostate interventional magnetic resonance imaging (MRI) is now routinely performed in many centers. Its more widespread acceptance is limited by the cost of the use of MRI largely related to the long duration time of the procedures. However, the...

Cite
Cornud F, Bomers J, Futterer JJ, et al. MR imaging-guided prostate interventional imaging: Ready for a clinical use?. Diagn Interv Imaging. 2018;99(11):743-753doi: 10.1016/j.diii.2018.08.002.
Cornud, F., Bomers, J., Futterer, J. J., Ghai, S., Reijnen, J. S., & Tempany, C. (2018). MR imaging-guided prostate interventional imaging: Ready for a clinical use?. Diagnostic and interventional imaging, 99(11), 743-753. https://doi.org/10.1016/j.diii.2018.08.002
Cornud, F, et al. "MR imaging-guided prostate interventional imaging: Ready for a clinical use?." Diagnostic and interventional imaging vol. 99,11 (2018): 743-753. doi: https://doi.org/10.1016/j.diii.2018.08.002
Cornud F, Bomers J, Futterer JJ, Ghai S, Reijnen JS, Tempany C. MR imaging-guided prostate interventional imaging: Ready for a clinical use?. Diagn Interv Imaging. 2018 Nov;99(11):743-753. doi: 10.1016/j.diii.2018.08.002. Epub 2018 Sep 03. PMID: 30190189.
Copy Download .nbib Format: NLM
Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials.

World journal of urology

Wang AZ, Lebastchi AH, O'Connor LP, Ahdoot M, Mehralivand S, Yerram N, Taneja SS, George AK, Sanchez-Salas R, Ward JF, Laguna P, de la Rosette J, Pinto PA.
PMID: 33388878
World J Urol. 2021 Mar;39(3):729-739. doi: 10.1007/s00345-020-03525-0. Epub 2021 Jan 02.

Focal therapy is growing as an alternative management options for men with clinically localized prostate cancer. Parallel to the increasing popularity of active surveillance (AS) as a treatment for low-risk disease, there has been an increased interest towards providing...

Cite
Wang AZ, Lebastchi AH, O'Connor LP, et al. Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials. World J Urol. 2021;39(3):729-739doi: 10.1007/s00345-020-03525-0.
Wang, A. Z., Lebastchi, A. H., O'Connor, L. P., Ahdoot, M., Mehralivand, S., Yerram, N., Taneja, S. S., George, A. K., Sanchez-Salas, R., Ward, J. F., Laguna, P., de la Rosette, J., & Pinto, P. A. (2021). Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials. World journal of urology, 39(3), 729-739. https://doi.org/10.1007/s00345-020-03525-0
Wang, Alex Z, et al. "Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials." World journal of urology vol. 39,3 (2021): 729-739. doi: https://doi.org/10.1007/s00345-020-03525-0
Wang AZ, Lebastchi AH, O'Connor LP, Ahdoot M, Mehralivand S, Yerram N, Taneja SS, George AK, Sanchez-Salas R, Ward JF, Laguna P, de la Rosette J, Pinto PA. Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials. World J Urol. 2021 Mar;39(3):729-739. doi: 10.1007/s00345-020-03525-0. Epub 2021 Jan 02. PMID: 33388878.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 24 entries